1.
Kardiologiia
; 44(2): 27-9, 2004.
Artigo
em Russo
| MEDLINE
| ID: mdl-15029132
RESUMO
The use of eprosartan (600-1200 mg/day for 4 weeks) in 28 patients with stage II hypertensive disease was associated with improvement of parameters of microcirculation and blood rheology.